Want to join the conversation?
Pharma giant $GILD said that the EU has granted authorization to market the once-daily Truvada combined with safer-sex practices to reduce risk of HIV-1 infection among high-risk uninfected adults, also known as pre-exposure prophylaxis (PrEP). Truvada is currently the most prescribed antiretroviral drug in Europe as part of combination therapy.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th